New anti-obesity medications : considerations and future directions in people with concurrent eating disorders

G. Sharp; T. Girolamo; Phillipa Hay; Deborah Mitchison; K. Cooper; P. Sumithran; H. Jebeile

doi:10.31128/AJGP-02-23-6731

New anti-obesity medications : considerations and future directions in people with concurrent eating disorders

G. Sharp
, T. Girolamo
, Phillipa Hay
, Deborah Mitchison
, K. Cooper
, P. Sumithran
, H. Jebeile

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Original language	English
Pages (from-to)	651-653
Number of pages	3
Journal	Australian Journal of General Practice
Volume	52
Issue number	9
DOIs	https://doi.org/10.31128/AJGP-02-23-6731
Publication status	Published - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.31128/AJGP-02-23-6731

Cite this

@article{4137ab152b4e4324b46566501e6dd9b2,

title = "New anti-obesity medications : considerations and future directions in people with concurrent eating disorders",

author = "G. Sharp and T. Girolamo and Phillipa Hay and Deborah Mitchison and K. Cooper and P. Sumithran and H. Jebeile",

year = "2023",

doi = "10.31128/AJGP-02-23-6731",

language = "English",

volume = "52",

pages = "651--653",

journal = "Australian Journal of General Practice",

issn = "2208-794X",

publisher = "Royal Australian College of General Practitioners",

number = "9",

}

TY - JOUR

T1 - New anti-obesity medications : considerations and future directions in people with concurrent eating disorders

AU - Sharp, G.

AU - Girolamo, T.

AU - Hay, Phillipa

AU - Mitchison, Deborah

AU - Cooper, K.

AU - Sumithran, P.

AU - Jebeile, H.

PY - 2023

Y1 - 2023

UR - https://hdl.handle.net/1959.7/uws:73638

U2 - 10.31128/AJGP-02-23-6731

DO - 10.31128/AJGP-02-23-6731

M3 - Article

C2 - 37666788

SN - 2208-794X

VL - 52

SP - 651

EP - 653

JO - Australian Journal of General Practice

JF - Australian Journal of General Practice

IS - 9

ER -

New anti-obesity medications : considerations and future directions in people with concurrent eating disorders

UN SDGs

Access to Document

Other files and links

Cite this